adenovirus rsv-tk
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2000 (NCT00005057)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adenovirus rsv-tk
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00005057 | Phase 1 | Mar 1, 2000 | National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2000 |
| National Human Genome Research Institute (NHGRI) | Government | 1 | 1 | 1 | 2000 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2000 |
3 organizations
Page 1 / 1